T3	Effect 0 16	Kaposi's sarcoma
T4	Subject 20 29	a patient
T5	Treatment 43 60	imatinib mesylate
T6	Treat-Disorder 65 89	chronic myeloid leukemia
T8	Drug 43 60	imatinib mesylate
T7	Adverse_event 30 37	treated
E1	Adverse_event:T7